A panel of experts on multiple myeloma share clinical practices and discuss the transition of care between academic and community oncology settings.
EP. 1: Identifying Potential Candidates for CAR T-Cell Therapy
A panel of experts on multiple myeloma introduce themselves and discuss the initial process of identifying patients who are potential candidates for CAR T-cell therapy.
EP. 2: Treating Patients Referred to Academic Centers for CAR T
Focusing on the transition of patients from community practices to academic centers, the panel discusses the initial evaluation and treatment processes, focusing on bridging therapy for patients awaiting CAR T.
EP. 3: CAR T-Cell Therapy: Leukapheresis Practices
Myeloma specialists discuss their approaches to determining the optimal timing for leukapheresis for patients awaiting CAR T-cell therapy.
EP. 4: Triaging and Prioritizing Patients with Multiple Myeloma
Experts on multiple myeloma provide clinical insights on how they triage and prioritize patients to best utilize available resources.
EP. 5: Transitioning Patients Back to Community Practices Following CAR T
Members of the panel discuss their criteria for determining when a patient is ready to transition back to community oncologists after they receive CAR T-cell therapy.
EP. 6: Monitoring Adverse Events Following CAR T-Cell Therapy
A panel of oncologists in academic and community settings discuss patient monitoring practices following CAR T-cell infusions, with a focus on neurotoxicities.